Triton’s primary project portfolio involves development of drug leads in the treatment of cancer, neuropsychiatric disorders, infectious diseases and applications of immune suppression. The establishment of a fine chemicals repository is a natural extension of this core research focus for new pharmaceuticals.
Triton anticipates many other benefits to human health in the use of marine natural products including marine derivatives beyond therapeutic applications. The company may expand its R&D scope in the future to pioneer marine natural product alternatives in other areas of global interest.
 |
Marine Natural Products. Key Advances to the Practical Application of this Resource in Drug Development |